Policy

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

PhRMA, U.S. Chamber warn of unintended consequences, market effects of negotiations.

Administration, HHS tout milestone day on road to lowering drug prices for beneficiaries.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

It's time for pharmaceutical companies and others to innovate and disrupt the distribution side of treatment.

AIMPA intends to become a new voice for physicians in independent practice.

Prescription drug prices, vaccine costs are also key issues.

In 2024, beneficiaries could see savings per dose, according to new guidance on price increases relative to inflation.

Independent doctors group says cuts would result in higher costs and less access to care for patients

Public-private partnerships will crumble, hurting drug innovation and eventually patients, Republicans say.

AIMPA intends to become a new voice for independent physicians across all specialties, including primary care.

AIMPA launches this week to advocate for specialists contending ‘consolidation has not led to better care or lower costs for patients.’

Advocacy takes time-a rarity for physicians. But there are five simple ways to advocate for needed healthcare changes.